• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Cardiovascular Trials Still Predominantly Led by Men, Study Finds

Cardiovascular Trials Still Predominantly Led by Men, Study Finds

April 11, 2022

A recent analysis of cardiovascular trials reveals that fewer than one in five trials were led by a female principal investigator (PI), suggesting there’s work to be done to achieve a greater rate of female leadership in heart research.

Researchers at the University of California, Berkeley reviewed 620 industry- and NIH-funded cardiovascular trials that took place from 2010 to 2019 and found no notable change in the proportion of female PIs in that time period.

The as-yet-unpublished study, presented at the recent annual American College of Cardiology Scientific Session meeting, found only 18.4 percent of the trials overall were led by females, with 18.9 percent of new drug and 9.6 percent of device trials having a female PI at the helm. Although women served more often as PIs for NIH-funded trials than for industry-sponsored trials, both saw low leadership rates (28.9 percent and 14.7 percent, respectively). A greater presence of female PIs may help make a dent in a historically lower proportion of female participants in cardiovascular trials, the findings suggest, as the trials led by women recruited 44.9 percent female participants compared to 37.9 percent in male-led studies.

 

To view more CenterWatch Weekly stories, click here.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing